Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Patterson

Showing results (571-580 of 599) with videos related to

Pageof 60
Sort By:
The European Respiratory Journal|March 3, 2022
Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statementEva Van Braeckel, Iain Page, Jesper Rømhild Davidsen, et al.
Emerging Infectious Diseases|October 18, 2011
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006Benjamin J Park, Peter G Pappas, Kathleen A Wannemuehler, et al.
Lancet (London, England)|December 20, 2015
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trialJohan A Maertens, Issam I Raad, Kieren A Marr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2010
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) DatabaseDimitrios P Kontoyiannis, Kieren A Marr, Benjamin J Park, et al.
Intensive Care Medicine|June 23, 2021
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosisPaul E Verweij, Roger J M Brüggemann, Elie Azoulay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Intensive Care Medicine|June 24, 2020
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinionPaul E Verweij, Bart J A Rijnders, Roger J M Brüggemann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupBen De Pauw, Thomas J Walsh, J Peter Donnelly, et al.
Nature|November 8, 2023
Tuning sterol extraction kinetics yields a renal-sparing polyene antifungalArun Maji, Corinne P Soutar, Jiabao Zhang, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Pageof 60

Showing results (571-580 of 599) with videos related to

Sort By:
Pageof 60
The European Respiratory Journal|March 3, 2022
Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statementEva Van Braeckel, Iain Page, Jesper Rømhild Davidsen, et al.
Emerging Infectious Diseases|October 18, 2011
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006Benjamin J Park, Peter G Pappas, Kathleen A Wannemuehler, et al.
Lancet (London, England)|December 20, 2015
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trialJohan A Maertens, Issam I Raad, Kieren A Marr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2010
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) DatabaseDimitrios P Kontoyiannis, Kieren A Marr, Benjamin J Park, et al.
Intensive Care Medicine|June 23, 2021
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosisPaul E Verweij, Roger J M Brüggemann, Elie Azoulay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Intensive Care Medicine|June 24, 2020
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinionPaul E Verweij, Bart J A Rijnders, Roger J M Brüggemann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupBen De Pauw, Thomas J Walsh, J Peter Donnelly, et al.
Nature|November 8, 2023
Tuning sterol extraction kinetics yields a renal-sparing polyene antifungalArun Maji, Corinne P Soutar, Jiabao Zhang, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Pageof 60